Michael John Chamberlin, PT | |
7315 212th St Sw, Suite 104, Edmonds, WA 98026-7610 | |
(425) 774-3226 | |
(425) 670-1406 |
Full Name | Michael John Chamberlin |
---|---|
Gender | Male |
Speciality | Physical Therapist |
Location | 7315 212th St Sw, Edmonds, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104917863 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | PT00002027 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Michael John Chamberlin, PT 7315 212th St Sw, Suite 104, Edmonds, WA 98026-7610 Ph: (425) 774-3226 | Michael John Chamberlin, PT 7315 212th St Sw, Suite 104, Edmonds, WA 98026-7610 Ph: (425) 774-3226 |
News Archive
In the first study of its kind, a team of international scientists led by UT Southwestern Medical Center and UCLA researchers have identified a dozen inherited traits related to sleep, wake, and activity cycles that are associated with severe bipolar disorder.
Cognizant today announced that Lumenis Ltd., the world's largest energy-based medical device company for aesthetic, surgical and ophthalmology applications, has deployed Cognizant MedVantage, a cloud-based integrated complaint handling solution.
Broad, deep and outstanding research in cancer science, treatment and prevention have earned The University of Texas MD Anderson Cancer Center a $48.6-million, five-year grant from the National Cancer Institute and an "exceptional" ranking, the highest possible, from the NCI's extensive peer-review process.
The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial.
Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.
› Verified 2 days ago
Carissa Renee Kono, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4145 | |
Lynn R Schafer, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8500 200th St Sw, Edmonds, WA 98026 Phone: 425-431-3050 | |
Tracie H Baylor, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 194 Sunset Ave, Edmonds, WA 98020 Phone: 425-776-3348 Fax: 425-776-3384 | |
Julie Foerster, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 23320 Highway 99, Edmonds, WA 98026 Phone: 425-640-5500 | |
Mrs. Meghan E Sueltenfuss, MSPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 21401 72nd Ave W, Edmonds, WA 98026 Phone: 425-412-1877 Fax: 425-339-4219 | |
Mountain2city Physical Therapy, Pllc Physical Therapist Medicare: Medicare Enrolled Practice Location: 100 2nd Ave S Ste 160, Edmonds, WA 98020 Phone: 206-601-6084 |